Mackay Shields LLC Meridian Bioscience Inc Transaction History

Mackay Shields LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$18.01 - $28.32 $1.37 Million - $2.16 Million	-76,312 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $1.83 Million - $2.76 Million	-92,488 Reduced 54.79%	76,312 $2 Million
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $722,007 - $994,194	45,900 Added 37.35%	168,800 $3.15 Million
Q3 2020 Nov 04, 2020	BUY	$13.54 - $26.41 $559,202 - $1.09 Million	41,300 Added 50.61%	122,900 $2.09 Million
Q2 2020 Jul 31, 2020	BUY	$7.84 - $23.29 $476,672 - $1.42 Million	60,800 Added 292.31%	81,600 $1.9 Million
Q1 2020 May 08, 2020	SELL	$5.57 - $11.5 $87,398 - $180,446	-15,691 Reduced 43.0%	20,800 $174,000
Q4 2019 Feb 11, 2020	SELL	$7.9 - $10.14 $167,480 - $214,968	-21,200 Reduced 36.75%	36,491 $356,000
Q3 2019 Nov 01, 2019	SELL	$9.17 - $12.01 $149,471 - $195,763	-16,300 Reduced 22.03%	57,691 $547,000
Q2 2019 Aug 13, 2019	BUY	$10.88 - $17.6 $805,022 - $1.3 Million	73,991 New	73,991 $879,000
Q2 2018 Aug 06, 2018	SELL	$13.8 - $16.8 $433,320 - $527,520	-31,400 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$13.8 - $16.2 $433,320 - $508,680	31,400 New	31,400 $446,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.